Adalat CC is a brand name of nifedipine, approved by the FDA in the following formulation(s):
ADALAT CC (nifedipine - tablet, extended release; oral)
Manufacturer: BAYER HLTHCARE
Approval date: April 21, 1993
Strength(s): 30MG [AB1], 60MG [RLD][AB1], 90MG [RLD][AB1]
Has a generic version of Adalat CC been approved?
Yes. The following products are equivalent to Adalat CC:
AFEDITAB CR (nifedipine tablet, extended release; oral)
Manufacturer: WATSON LABS
Approval date: March 10, 2000
Strength(s): 30MG [AB1]
Manufacturer: WATSON LABS
Approval date: October 26, 2001
Strength(s): 60MG [AB1]
nifedipine tablet, extended release; oral
Manufacturer: ACTAVIS
Approval date: December 13, 2006
Strength(s): 30MG [AB1], 60MG [AB1]
Manufacturer: MYLAN
Approval date: December 3, 2010
Strength(s): 30MG [AB1], 60MG [AB1], 90MG [AB1]
Manufacturer: VALEANT INTL
Approval date: December 4, 2000
Strength(s): 30MG [AB1], 60MG [AB1]
Manufacturer: VALEANT INTL
Approval date: August 16, 2002
Strength(s): 90MG [AB1]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Adalat CC. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Adalat CC.
See also...
- Adalat CC Sustained-Release Tablets Consumer Information (Wolters Kluwer)
- Adalat CC Consumer Information (Cerner Multum)
- Adalat CC Advanced Consumer Information (Micromedex)
- Nifedipine Consumer Information (Drugs.com)
- Nifedipine Consumer Information (Wolters Kluwer)
- Nifedipine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
- Nifedipine Consumer Information (Cerner Multum)
- Nifedipine Advanced Consumer Information (Micromedex)
- Nifedipine AHFS DI Monographs (ASHP)
No comments:
Post a Comment